- Exchange: NASDAQ GM
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Therapeutics
Transition Therapeutics Inc+ Add to Watchlist
TTHI:US2.9000 USD 0.0200 0.69%
As of 20:10:00 ET on 05/17/2013.
Company Profile for Transition Therapeutics Inc (TTHI)
Transition Therapeutics Inc. is a biopharmaceutical company focused on developing novel therapeutics in order to address global medical needs in large disease indications, including Alzheimer's disease and diabetes.
Transition Therapeutics Inc
Key Executives for Transition Therapeutics Inc (TTHI)
|Tony F CruzChairman/CEO||Nicole Rusaw GeorgeChief Financial Officer|
|Aleksandra PastrakVP:Clinical Dev/Medical Ofcr||Carl DamianiVP:Business Development|
|Bruce ConnopVP:Non-Clinical & Pharma Dev||Louis AlexopoulosSecretary|